Welcome to LookChem.com Sign In|Join Free

CAS

  • or

37904-03-3

Post Buying Request

37904-03-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

37904-03-3 Usage

Description

4-OXO-4-(4-TOLUIDINO)BUT-2-ENOIC ACID is a chemical compound characterized by the molecular formula C13H13NO3. It is a carboxylic acid derivative that features a 4-oxo-4-(4-toluidino)but-2-enoic acid functional group. 4-OXO-4-(4-TOLUIDINO)BUT-2-ENOIC ACID is recognized for its potential pharmacological properties and is frequently utilized in the realms of organic synthesis and pharmaceutical research.

Uses

Used in Organic Synthesis:
4-OXO-4-(4-TOLUIDINO)BUT-2-ENOIC ACID is used as a key intermediate in organic synthesis for the creation of various chemical compounds. Its unique functional group allows for versatile reactions and the formation of a wide array of products.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 4-OXO-4-(4-TOLUIDINO)BUT-2-ENOIC ACID is used as a research compound to explore its potential pharmacological properties. Scientists are interested in its possible applications in drug development due to its chemical structure and reactivity.
Used in Drug Development:
4-OXO-4-(4-TOLUIDINO)BUT-2-ENOIC ACID may be employed in the development of new drugs. Its specific functional group could contribute to the creation of pharmaceuticals with novel mechanisms of action or improved therapeutic effects.
Used in Therapeutic Research:
4-OXO-4-(4-TOLUIDINO)BUT-2-ENOIC ACID is also being studied for its potential therapeutic effects. As research progresses, it may reveal new insights into how 4-OXO-4-(4-TOLUIDINO)BUT-2-ENOIC ACID could be utilized in treating various medical conditions.
The exact uses and properties of 4-OXO-4-(4-TOLUIDINO)BUT-2-ENOIC ACID are still under investigation, with ongoing research aimed at uncovering its full potential across different applications and industries.

Check Digit Verification of cas no

The CAS Registry Mumber 37904-03-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,7,9,0 and 4 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 37904-03:
(7*3)+(6*7)+(5*9)+(4*0)+(3*4)+(2*0)+(1*3)=123
123 % 10 = 3
So 37904-03-3 is a valid CAS Registry Number.
InChI:InChI=1/C11H11NO3/c1-8-2-4-9(5-3-8)12-10(13)6-7-11(14)15/h2-7H,1H3,(H,12,13)(H,14,15)/b7-6-

37904-03-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-OXO-4-(4-TOLUIDINO)BUT-2-ENOIC ACID

1.2 Other means of identification

Product number -
Other names N-p-Tolyl-maleamidsaeure

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:37904-03-3 SDS

37904-03-3Relevant articles and documents

Design, synthesis and biochemical evaluation of novel ethanoanthracenes and related compounds to target burkitt’s lymphoma

Byrne, Andrew J.,Bright, Sandra A.,McKeown, James P.,O’brien, John E.,Twamley, Brendan,Fayne, Darren,Williams, D. Clive,Meegan, Mary J.

, (2020/01/31)

Lymphomas (cancers of the lymphatic system) account for 12% of malignant diseases worldwide. Burkitt’s lymphoma (BL) is a rare form of non-Hodgkin’s lymphoma in which the cancer starts in the immune B-cells. We report the synthesis and preliminary studies on the antiproliferative activity of a library of 9,10-dihydro-9,10-ethanoanthracene based compounds structurally related to the antidepressant drug maprotiline against BL cell lines MUTU-1 and DG- 75. Structural modifications were achieved by Diels-Alder reaction of the core 9-(2- nitrovinyl)anthracene with number of dienophiles including maleic anhydride, maleimides, acrylonitrile and benzyne. The antiproliferative activity of these compounds was evaluated in BL cell lines EBV? MUTU-1 and EBV+ DG-75 (chemoresistant). The most potent compounds 13j, 15, 16a, 16b, 16c, 16d and 19a displayed IC50 values in the range 0.17–0.38 μM against the BL cell line EBV? MUTU-1 and IC50 values in the range 0.45–0.78 μM against the chemoresistant BL cell line EBV+ DG- 75. Compounds 15, 16b and 16c demonstrated potent ROS dependent apoptotic effects on the BL cell lines which were superior to the control drug taxol and showed minimal cytotoxicity to peripheral blood mononuclear cells (PBMCs). The results suggest that this class of compounds merits further investigation as antiproliferative agents for BL.

Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents

Ji, Qinggang,Li, Baihui,Shen, Yangli,Wu, Hu,Wu, Xiaobo,Yuan, Lvjiang

, (2020/04/15)

A series of 3,4-dihydro-2(1H)-quinolinone derivatives contained butenediamide fragment were designed and synthesized. Their inhibition potency against chitin synthase and antimicrobial activities were screened in vitro. The enzymatic assays showed that all the synthesized compounds had inhibition potency against chitin synthase at concentration of 300 μg/mL. Compound 2d displayed excellent potency with inhibition percentage (IP) value of 82.3%, while IP value of the control polyoxin B was 87.5%. Compounds 2b, 2e and 2s whose IP values were above 70% showed good inhibition potency against chitin synthase. Moreover, the IC50 value of 2b was comparable with that of polyoxin B (0.09 mM). The Ki of compound 2b was 0.12 mM and the result from Lineweaver-Burk plot showed that 2b was non-competitive inhibitor to bind chitin synthase. The antifungal experiment showed that these compounds had excellent antifungal activity against fungal strains, especially for candida albicans. The antifungal activities against C .albicans of compounds 2b, 2d, 2e and 2l were comparable with that of fluconazole and were superior to that of polyoxin B. Meanwhile, the other compounds against C. albicans showed better antifungal activity (MIC 2 μg/mL) than polyoxin B except for compound 2n (MIC 4 μg/mL). The trial of drug combination use showed that these synthesized compounds had synergistic effects with fluconazole and polyoxin B. It indicated that these compounds were not competing with polyoxin B to bind with chitin synthase, which was also consistence with the result of enzymatic assays. The antibacterial experiment showed that these compounds had no activity against selected strains including three Gram-positive and three Gram-negative bacteria. These results showed that the designed compounds were chitin synthase inhibitors and had selective antifungal activity.

Visible light mediated cyclization of tertiary anilines with maleimides using nickel(II) oxide surface-modified titanium dioxide catalyst

Tang, Jian,Grampp, Günter,Liu, Yun,Wang, Bing-Xiang,Tao, Fei-Fei,Wang, Li-Jun,Liang, Xue-Zheng,Xiao, Hui-Quan,Shen, Yong-Miao

supporting information, p. 2724 - 2732 (2015/03/18)

Surface-modified titanium dioxides by highly dispersed NiO particles have an extended absorption in the visible light region and a reduced hole-electron pair recombination than unmodified TiO2. They have now been successfully applied as highly active heterogeneous photocatalysts in the visible light mediated direct cyclization of tertiary anilines with maleimides to give tetrahydroquinoline products in moderate to high yields at ambient temperature. In contrast with unmodified titanium dioxide catalysts that are conventionally used in a stoichiometric amount in combination with UVA light, only a catalytic amount (1 mol %) of the surface-modified TiO2 catalyst is needed along with visible light to efficiently catalyze the reaction. Compared with transition-metal complexes such as Ru(bpy)3Cl2 or Ir(ppy)2(dtbbpy)PF6, advantages of these surface-modified titanium dioxides as photocatalyst include high catalytic activity, low cost, ease of recovering, and being able to be used for at least nine times without significant decay of catalytic activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 37904-03-3